Topographic mapping of EEG during sleep.

Topographic aspects of all night sleep EEG were investigated in 10 healthy volunteers (age 20-35 years). EEG brain maps showed an increase of delta power from stage 1 to 4, a decrease of alpha power most pronounced parieto-occipitally and a slowing of the dominant alpha frequency. Differences of EEG power in different sleep stages (as compared to wakefulness) are displayed topographically. Analysis of the course of stage 2 showed an increase of delta power and a decrease of theta power in the first sections of the night, and an increase of beta power later in the night.

[The prognostic value of evoked potentials in early neurologic rehabilitation of patients with the apallic syndrome]. / Prognostische Wertigkeit evozierter Potentiale in der neurologischen Frührehabilitation bei Patienten im apallischen Syndrom.

In 22 patients with apallic syndrome brainstem auditory and somatosensory evoked potentials were recorded, in 8 patients the course during rehabilitation was observed. Clinically the patients were scored with Glasgow-coma scale, Karnofsky-index and Goldenberg-scale. The outcome of rehabilitation was estimated by the "Glasgow-outcome scale". No correlation was found between results of evoked potentials and clinical state. First evoked potentials measurements of apallic patients allowed no prognosis. Evoked potentials are an important prognostic factor after severe head trauma, but have no value for the prognosis of apallic patients.

[The significance of laboratory findings in long-term antiepileptic therapy]. / Bedeutung von Laboratoriumsbefunden bei Antiepileptika-Langzeittherapie.

A retrospective study of 316 patients (173 men, 143 women; mean age 39 [17-87] years) who had taken antiepileptics (phenytoin, phenobarbital, carbamazepine, valproic acid) for at least six months, was carried out to assess the biochemical and haematological changes in relation to the drug used, the therapeutic programme and the drug serum levels. The most frequent change was isolated elevation of gamma-GT (9-89% of cases depending on the drug), followed by elevation of alkaline phosphatase (16-44%). Increases in the transaminases GOT (4-13%) and GPT (4-19%) were infrequent and minor. Changes in the blood picture were very infrequent and never more than minimal. Correlation between all these changes and serum drug levels was poor (r less than 0.15). Correlations between drug serum level and dose were found in the case of phenobarbital (r = 0.6) and valproic acid (r = 0.5). There was hence no evidence of any clear connection between the biochemical findings and the serum concentrations of antiepileptic drugs or their-dosage. The results indicate that undue importance has previously been attached to routine checks of biochemical parameters; abnormal biochemical findings by themselves are not usually enough to necessitate changes in treatment. Determination of biochemical and haematological parameters is necessary only if there are clinical grounds for it such as suspicion of side effects, the occurrence of epileptic attacks despite therapy, or change from one drug to another.

[Possibilities and limitations of the automatic analysis of sleep stages using the Oxford system]. / Möglichkeiten und Beschränkungen der automatischen Schlafstadienanalyse mit dem Oxford-System.

34 ambulatory polygraphic sleep-records of young adults were carried out using the Oxford Medilog 9000 recorder. All of the records underwent automatic evaluation by the Oxford Sleep Stager. 10 cases were, in addition, evaluated visually. 4 records could not be analyzed because of artifacts. Thus, 30 subjects were used in the end for establishing standard values of sleep parameters. Automatic versus automatic comparisons and automatic versus visual comparisons of ten polysomnograms were performed epoch-by-epoch. The automatic versus automatic comparison showed agreement in 85.5% of epochs, and the automatic versus visual comparison in 70.4% of epochs. The Sleep Stager showed the best agreement with the visual evaluation in epoch-by-epoch comparison in the REM-stage (93.9%), the worst in stage 1 (32.4%). In calculating the percentages of total night sleep for the respective sleep stages, the automatic analysis showed strongest disagreement with visual evaluation in the REM-stage (plus 7.5%) and in stage 2 (minus 5.2%).